Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism, biomarkers and management
Background: Doxorubicin (DOX) is a widely used chemotherapeutic agent that is effective against various solid tumors and hematologic malignancies. However, its clinical application is severely limited by dose-dependent cardiotoxicity, which affects nearly 26% of patients. Objective: This review focu...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Creative Pharma Assent
2024-12-01
|
| סדרה: | Journal of Applied Pharmaceutical Research |
| נושאים: | |
| גישה מקוונת: | https://japtronline.com/index.php/joapr/article/view/673 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|